Novaferon

DB16483InvestigationalProtein Based Therapies

Novaferon: Overview.

Mechanism: Novaferon is a recombinant interferon with antitumor and antiviral activities which binds to interferon receptor 2. The mechanism behind its antitumor activity may be due to S-phase arrest, pro-apoptosis, and angiogenesis inhibition.
Curator reviewed
Also known as: Recombinant Interferon Alpha 2b-like Protein

Resolves to

Compound

Targets

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Novaferon, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.